PRODUCT FILTER
Categories
Type
Type

Diltiazem STELLA 60 mg
Rx

Diltiazem is a benzothiazepine calcium-channel blocking agent. It increases exercise capacity and improves all indices of myocardial ischaemia in the angina patient.

 

 

Pack size Box of 30 tablets; Bottle of 100 tablets.
Shelf-life 24 months
Composition Diltiazem Hydrochloride
Dosage forms and strengths Tablet: 60 mg.
Product code :

PRESCRIBING INFORMATION

Indications:

Prophylaxis and treatment of angina pectoris.

Dosage:

  • Adults: The usual dose is 1 tablet three times daily. If necessary the divided dose may be increased to 6 tablets daily. Higher doses up to 8 tablets daily have been used with benefit in some patients especially in unstable angina.
  • Elderly and patients with impaired hepatic or renal function: The starting dose is one tablet twice daily. The dose should not be increased if the heart rate falls below 50 beats per minute.
  • Diltiazem is not recommended for use in children.

Usage:

Diltiazem STELLA 60 mg is administered orally. It should be taken with a glass of water before meals, swallowed the whole tablet, should not be chewed, broken, crushed.

  • Known hypersensitivity to any of the active substance or excipients.
  • Sinus dysfunction.
  • 2nd and 3rd degree atrioventricular block.
  • Left ventricular failure with pulmonary stasis.
  • Severe bradycardia (less than 50 beats per minute)
  • Lactation.
  • Concurrent use with dantrolene infusion
  • Combination with ivabradine
  • Patients with severe hypotension (less than 90 mmHg systolic)
  • Patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.
  • Peripheral oedema.
  • Headache, dizziness.
  • Atrioventricular block, palpitations.
  • Flushing.
  • Constipation, dyspepsia, gastric pain, nausea.
  • Erythema, Malaise.
  • Use with caution in patients with reduced left ventricular function, bradycardia or with a 1st degree AV block or prolonged PR interval detected on the electrocardiogram; in patients at risk of developing an intestinal obstruction; patients with latent or manifest due to a possible increase in blood glucose.
  • Drug discontinuation should be considered if mood changes, including depression.
  • Diltiazem is not recommended during pregnancy, as well as in women of child-bearing potential not using effective contraception. Breastfeeding is not recommended during drug administration.
  • Patients should be aware of how they react to drug before driving or operating machinery.